Meeting of the Uniform Formulary Beneficiary Advisory Panel, 66368 [05-21780]

Download as PDF 66368 Federal Register / Vol. 70, No. 211 / Wednesday, November 2, 2005 / Notices DEPARTMENT OF DEFENSE GENERAL SERVICES ADMINISTRATION NATIONAL AERONAUTICS AND SPACE ADMINISTRATION [OMB Control No. 9000–0154] Federal Acquisition Regulation; Information Collection; Davis Bacon Act—Price Adjustment (Actual Method) Department of Defense (DOD), General Services Administration (GSA), and National Aeronautics and Space Administration (NASA). ACTION: Notice of request for public comments regarding an extension to an existing OMB clearance. AGENCIES: SUMMARY: Under the provisions of the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35), the Federal Acquisition Regulation (FAR) Secretariat will be submitting to the Office of Management and Budget (OMB) a request to review and approve an extension of a currently approved information collection requirement concerning the Davis-Bacon Act price adjustment (actual method). The clearance currently expires on March 31, 2006. Public comments are particularly invited on: Whether this collection of information is necessary for the proper performance of functions of the FAR, and whether it will have practical utility; whether our estimate of the public burden of this collection of information is accurate, and based on valid assumptions and methodology; ways to enhance the quality, utility, and clarity of the information to be collected; and ways in which we can minimize the burden of the collection of information on those who are to respond, through the use of appropriate technological collection techniques or other forms of information technology. DATES: Submit comments on or before January 3, 2006. ADDRESSES: Submit comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to the General Services Administration, Regulatory Secretariat (VIR), 1800 F Street, NW, Room 4035, Washington, DC 20405. Kimberly Marshall, Contract Policy Division, GSA, (202) 219–0986. SUPPLEMENTARY INFORMATION: A. Purpose The clause at 52.222–32, Davis-Bacon Act—Price Adjustment (Actual 17:22 Nov 01, 2005 Jkt 208001 B. Annual Reporting Burden Respondents: 900. Responses Per Respondent: 1. Annual Responses: 900. Hours Per Response: 90. Total Burden Hours: 81,000. Obtaining Copies of Proposals: Requesters may obtain a copy of the information collection documents from the General Services Administration, FAR Secretariat (VIR), Room 4035, 1800 F Street, NW, Washington, DC 20405, telephone (202) 501–4755. Please cite OMB Control No. 9000–0154, DavisBacon Act—Price Adjustment (Actual Method), in all correspondence. Dated: October 20, 2005. Gerald Zaffos, Director, Contract Policy Division. [FR Doc. 05–21787 Filed 11–1–05; 8:45 am] BILLING CODE 6820–EP–S meeting will be open to the public. Seating is limited and will be provided only to the first 220 people signing in. All persons must sign in legibly. Notice of this meeting is required under the Federal Advisory Committee Act. DATES: Friday, December 16, 2005, from 8 a.m. to 4 p.m. ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue, NW., Washington, DC 20004. FOR FURTHER INFORMATION CONTACT: Mr. Rich Martel, TRICARE Management Activity, Pharmacy Operations, Beneficiary Advisory Panel, Suite 810, 5111 Leesburg Pike, Falls Church, VA 22041, telephone (703) 681–0064 ext. 3672, fax (703) 681–1242,or e-mail at richard.martel.ctr@tma.osd.mil. SUPPLEMENTARY INFORMATION: The Uniform Formulary Beneficiary Advisory Panel will only review and comment on the development of the Uniform Formulary as reflected in the recommendations of the DoD Pharmacy and Therapeutics (P&T) Committee coming out of that body’s meeting in November 2005. The P&T Committee information and subject matter concerning drug classes reviewed for that meeting are available at https:// pec.ha.osd.mil. Any private citizen is permitted to file a written statement with the advisory panel. Statements must be submitted electronically to richard.martel.ctr@tma.osd.mil no later than December 9, 2005. Any private citizen is permitted to speak at the Beneficiary Advisory Panel meeting, time permitting. One hour will be reserved for public comments, and speaking times will be assigned only to the first twelve citizens to sign up at the meeting, on a first-come, first-served basis. The amount of time allocated to a speaker will not exceed five minutes. Dated: October 26, 2005. L.M. Bynum, Alternate OSD Federal Register Liaison Officer, DoD. [FR Doc. 05–21780 Filed 11–1–05; 8:45 am] DEPARTMENT OF DEFENSE Office of the Secretary BILLING CODE 5001-06-M Meeting of the Uniform Formulary Beneficiary Advisory Panel Department of Defense, Assistant Secretary of Defense (Health Affairs). ACTION: Notice of meeting. AGENCY: This notice announces a meeting of the Uniform Formulary Beneficiary Advisory Panel. The panel will review and comment on recommendations made to the Director, TRICARE Management Activity, by the Pharmacy and Therapeutics Committee regarding the Uniform Formulary. The SUMMARY: FOR FURTHER INFORMATION CONTACT VerDate Aug<31>2005 Method), requires that a contractor must submit at the exercise of each option to extend the term of the contract, a statement of the amount claimed for incorporation of the most current wage determination by the Department of Labor, and any relevant supporting data, including payroll records, that the contracting officer may reasonably require. The contracting officer may include this clause in fixed-price solicitations and contracts, subject to the DavisBacon Act, that will contain option provisions to extend the term of the contract and the Contracting Officer determines the most appropriate method to establish contract price is the method at 22.404–12(c)(4). Generally, this method is only appropriate if contract requirements are predominantly services subject to the Service Contract Act and the construction requirements are substantial and segregable. PO 00000 Frm 00022 Fmt 4703 Sfmt 4703 DEPARTMENT OF EDUCATION Submission for OMB Review; Comment Request Department of Education. The Leader, Information Management Case Services Team, Regulatory Information Management Services, Office of the Chief Information Officer invites comments on the submission for OMB review as required by the Paperwork Reduction Act of 1995. AGENCY: SUMMARY: E:\FR\FM\02NON1.SGM 02NON1

Agencies

[Federal Register Volume 70, Number 211 (Wednesday, November 2, 2005)]
[Notices]
[Page 66368]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-21780]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Meeting of the Uniform Formulary Beneficiary Advisory Panel

AGENCY: Department of Defense, Assistant Secretary of Defense (Health 
Affairs).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces a meeting of the Uniform Formulary 
Beneficiary Advisory Panel. The panel will review and comment on 
recommendations made to the Director, TRICARE Management Activity, by 
the Pharmacy and Therapeutics Committee regarding the Uniform 
Formulary. The meeting will be open to the public. Seating is limited 
and will be provided only to the first 220 people signing in. All 
persons must sign in legibly. Notice of this meeting is required under 
the Federal Advisory Committee Act.

DATES: Friday, December 16, 2005, from 8 a.m. to 4 p.m.

ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue, NW., 
Washington, DC 20004.

FOR FURTHER INFORMATION CONTACT: Mr. Rich Martel, TRICARE Management 
Activity, Pharmacy Operations, Beneficiary Advisory Panel, Suite 810, 
5111 Leesburg Pike, Falls Church, VA 22041, telephone (703) 681-0064 
ext. 3672, fax (703) 681-1242,or e-mail at 
richard.martel.ctr@tma.osd.mil.

SUPPLEMENTARY INFORMATION: The Uniform Formulary Beneficiary Advisory 
Panel will only review and comment on the development of the Uniform 
Formulary as reflected in the recommendations of the DoD Pharmacy and 
Therapeutics (P&T) Committee coming out of that body's meeting in 
November 2005. The P&T Committee information and subject matter 
concerning drug classes reviewed for that meeting are available at 
https://pec.ha.osd.mil. Any private citizen is permitted to file a 
written statement with the advisory panel. Statements must be submitted 
electronically to richard.martel.ctr@tma.osd.mil no later than December 
9, 2005. Any private citizen is permitted to speak at the Beneficiary 
Advisory Panel meeting, time permitting. One hour will be reserved for 
public comments, and speaking times will be assigned only to the first 
twelve citizens to sign up at the meeting, on a first-come, first-
served basis. The amount of time allocated to a speaker will not exceed 
five minutes.

    Dated: October 26, 2005.
L.M. Bynum,
Alternate OSD Federal Register Liaison Officer, DoD.
[FR Doc. 05-21780 Filed 11-1-05; 8:45 am]
BILLING CODE 5001-06-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.